Literature DB >> 17502402

Pyrophosphorolytic excision of nonobligate chain terminators by hepatitis C virus NS5B polymerase.

Jérôme Deval1, Megan H Powdrill, Claudia M D'Abramo, Luciano Cellai, Matthias Götte.   

Abstract

Nonobligate chain terminators, such as 2'-C-methylated nucleotides, block RNA synthesis by the RNA-dependent RNA polymerase (RdRp) of hepatitis C virus (HCV). Previous studies with related viral polymerases have shown that classical chain terminators lacking the 3'-hydroxyl group can be excised in the presence of pyrophosphate (PP(i)), which is detrimental to the inhibitory activity of these compounds. Here we demonstrate that the HCV RdRp enzyme is capable of removing both obligate and clinically relevant nonobligate chain terminators. Pyrimidines are more efficiently excised than are purines. The presence of the next complementary templated nucleotide literally blocks the excision of obligate chain terminators through the formation of a dead-end complex (DEC). However, 2'-C-methylated CMP is still cleaved efficiently under these conditions. These findings show that a 2'-methylated primer terminus impedes nucleotide binding. The S282T mutation, associated with resistance to 2'-C-methylated nucleotides, does not affect the excision patterns. Thus, the decreased susceptibility to 2'-C-methylated nucleotides appears to be based solely on improved discrimination between the inhibitor and its natural counterpart. In conclusion, our data suggest that the phosphorolytic excision of nonobligate, pyrimidine-based chain terminators can diminish their potency. The templated nucleotide does not appear to provide protection from excision through DEC formation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17502402      PMCID: PMC1932539          DOI: 10.1128/AAC.00186-07

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  45 in total

1.  Peginterferon alfa-2a in patients with chronic hepatitis C.

Authors:  S Zeuzem; S V Feinman; J Rasenack; E J Heathcote; M Y Lai; E Gane; J O'Grady; J Reichen; M Diago; A Lin; J Hoffman; M J Brunda
Journal:  N Engl J Med       Date:  2000-12-07       Impact factor: 91.245

2.  Cell-free replication of the hepatitis C virus subgenomic replicon.

Authors:  Naushad Ali; Keith D Tardif; Aleem Siddiqui
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 3.  Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome.

Authors:  H J Alter; L B Seeff
Journal:  Semin Liver Dis       Date:  2000       Impact factor: 6.115

4.  Template requirements for RNA synthesis by a recombinant hepatitis C virus RNA-dependent RNA polymerase.

Authors:  C C Kao; X Yang; A Kline; Q M Wang; D Barket; B A Heinz
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Differential removal of thymidine nucleotide analogues from blocked DNA chains by human immunodeficiency virus reverse transcriptase in the presence of physiological concentrations of 2'-deoxynucleoside triphosphates.

Authors:  P R Meyer; S E Matsuura; R F Schinazi; A G So; W A Scott
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

6.  Phenotypic mechanism of HIV-1 resistance to 3'-azido-3'-deoxythymidine (AZT): increased polymerization processivity and enhanced sensitivity to pyrophosphate of the mutant viral reverse transcriptase.

Authors:  D Arion; N Kaushik; S McCormick; G Borkow; M A Parniak
Journal:  Biochemistry       Date:  1998-11-10       Impact factor: 3.162

7.  De novo initiation of RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase.

Authors:  W Zhong; A S Uss; E Ferrari; J Y Lau; Z Hong
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

8.  Template/primer requirements and single nucleotide incorporation by hepatitis C virus nonstructural protein 5B polymerase.

Authors:  W Zhong; E Ferrari; C A Lesburg; D Maag; S K Ghosh; C E Cameron; J Y Lau; Z Hong
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

9.  A novel mechanism to ensure terminal initiation by hepatitis C virus NS5B polymerase.

Authors:  Z Hong; C E Cameron; M P Walker; C Castro; N Yao; J Y Lau; W Zhong
Journal:  Virology       Date:  2001-06-20       Impact factor: 3.616

10.  Selection of 3'-template bases and initiating nucleotides by hepatitis C virus NS5B RNA-dependent RNA polymerase.

Authors:  Jae Hoon Shim; Gary Larson; Jim Zhen Wu; Zhi Hong
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

View more
  22 in total

1.  Synthesis and antiviral activity of 2'-deoxy-2'-fluoro-2'-C-methyl-7-deazapurine nucleosides, their phosphoramidate prodrugs and 5'-triphosphates.

Authors:  Junxing Shi; Longhu Zhou; Hongwang Zhang; Tamara R McBrayer; Mervi A Detorio; Melissa Johns; Leda Bassit; Megan H Powdrill; Tony Whitaker; Steven J Coats; Matthias Götte; Raymond F Schinazi
Journal:  Bioorg Med Chem Lett       Date:  2011-09-29       Impact factor: 2.823

Review 2.  The uncoupling of catalysis and translocation in the viral RNA-dependent RNA polymerase.

Authors:  Bo Shu; Peng Gong
Journal:  RNA Biol       Date:  2017-03-01       Impact factor: 4.652

3.  Biochemical Evaluation of the Inhibition Properties of Favipiravir and 2'-C-Methyl-Cytidine Triphosphates against Human and Mouse Norovirus RNA Polymerases.

Authors:  Zhinan Jin; Kathryn Tucker; Xiaoyan Lin; C Cheng Kao; Ken Shaw; Hua Tan; Julian Symons; Ishani Behera; Vivek K Rajwanshi; Natalia Dyatkina; Guangyi Wang; Leo Beigelman; Jerome Deval
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

4.  2'-C-methylated nucleotides terminate virus RNA synthesis by preventing active site closure of the viral RNA-dependent RNA polymerase.

Authors:  Alyson K Boehr; Jamie J Arnold; Hyung S Oh; Craig E Cameron; David D Boehr
Journal:  J Biol Chem       Date:  2019-10-01       Impact factor: 5.157

5.  Discovery of novel ribonucleoside analogs with activity against human immunodeficiency virus type 1.

Authors:  Michael J Dapp; Laurent Bonnac; Steven E Patterson; Louis M Mansky
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

6.  Structural basis of HIV-1 resistance to AZT by excision.

Authors:  Xiongying Tu; Kalyan Das; Qianwei Han; Joseph D Bauman; Arthur D Clark; Xiaorong Hou; Yulia V Frenkel; Barbara L Gaffney; Roger A Jones; Paul L Boyer; Stephen H Hughes; Stefan G Sarafianos; Eddy Arnold
Journal:  Nat Struct Mol Biol       Date:  2010-09-19       Impact factor: 15.369

Review 7.  HIV-1 reverse transcriptase and antiviral drug resistance. Part 2.

Authors:  Kalyan Das; Eddy Arnold
Journal:  Curr Opin Virol       Date:  2013-04-19       Impact factor: 7.090

8.  Delayed chain termination protects the anti-hepatitis B virus drug entecavir from excision by HIV-1 reverse transcriptase.

Authors:  Egor P Tchesnokov; Aleksandr Obikhod; Raymond F Schinazi; Matthias Götte
Journal:  J Biol Chem       Date:  2008-10-20       Impact factor: 5.157

9.  Inhibition of hepatitis C viral RNA-dependent RNA polymerase by α-P-boranophosphate nucleotides: exploring a potential strategy for mechanism-based HCV drug design.

Authors:  Marcus Adrian Cheek; Mariam L Sharaf; Mikhail I Dobrikov; Barbara Ramsay Shaw
Journal:  Antiviral Res       Date:  2013-03-04       Impact factor: 5.970

10.  Mechanism of hepatitis C virus RNA polymerase inhibition with dihydroxypyrimidines.

Authors:  Megan H Powdrill; Jerome Deval; Frank Narjes; Raffaele De Francesco; Matthias Götte
Journal:  Antimicrob Agents Chemother       Date:  2009-12-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.